Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Ireland CDMO Directory · Craigavon, Co. Armagh

Almac Group Craigavon

Peptide Synthesis & Commercial Drug Product

Thousands of staff (NI's largest indigenous life sciences employer)
Employees
Global HQ Campus
Facility
Armagh
County
4
Certifications

Facility Overview

Opened a £65M, 100,000 sq ft commercial manufacturing facility in March 2025 for oral dose and potent drug products, alongside a separate 28,000 sq ft GMP peptide API synthesis plant (completed 2024) supporting growing demand for peptide therapeutics.

£65M commercial facility (2025) plus 28,000 sq ft peptide synthesis plant (2024)

Capabilities

Peptide API Manufacturing Commercial Drug Product Clinical Trial Supply Sachet Formulation Drug Discovery

Certifications & Regulatory Licenses

FDA Approved EMA (EU GMP) MHRA ISO 9001
Sourcing & Facility Audit

Considering Almac Group Craigavon for your shortlist?

Tell us your molecule type, dosage form, batch size, and target markets. We coordinate a direct introduction and independent facility assessment.

Request Sourcing & Audit →